• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Top 3 Defensive Stocks That Are Ticking Portfolio Bombs

    7/25/24 9:28:41 AM ET
    $BTI
    $MO
    $UL
    Medicinal Chemicals and Botanical Products
    Health Care
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BTI alert in real time by email

    As of July 25, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

    The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.

    Here's the latest list of major overbought players in this sector.

    Unilever plc (NYSE:UL)

    • On July 25, Unilever reported quarterly adjusted earnings of $1.74 per share. This is a 16.27% increase over earnings of $1.50 per share from the same period last year. The company reported $33.48 billion in sales this quarter. The company's stock gained around 19% over the past six months and has a 52-week high of $58.62.
    • RSI Value: 71.27                              
    • UL Price Action: Shares of Unilever gained 0.04% to close at $56.54 on Wednesday.

    British American Tobacco PLC (NYSE:BTI)

    • On July 25, British American Tobacco posted H1 adjusted EPS of 169.3p down from 181.6p year over year. The company's stock gained around 4% over the past month and has a 52-week high of $34.15.
    • RSI Value: 77.99
    • BTI Price Action: Shares of British American Tobacco fell slightly to close at $33.38 on Wednesday.

    Altria Group Inc (NYSE:MO)

    • Altria Group will report its second-quarter and first-half business results on July 31. The company's stock gained around 6% over the past month and has a 52-week high of $49.92.
    • RSI Value: 76.01
    • MO Price Action: Shares of Altria closed at $49.42 on Wednesday.

    Read More:

    • Over $1M Bet On United Security Bancshares? Check Out These 3 Stocks Insiders Are Buying
    Get the next $BTI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BTI
    $MO
    $UL

    CompanyDatePrice TargetRatingAnalyst
    Unilever PLC
    $UL
    2/9/2026Buy → Hold
    Deutsche Bank
    Altria Group Inc.
    $MO
    1/9/2026$63.00Neutral → Buy
    UBS
    Unilever PLC
    $UL
    1/8/2026$71.00Outperform → Neutral
    BNP Paribas Exane
    Unilever PLC
    $UL
    12/15/2025$60.10Overweight
    Morgan Stanley
    British American Tobacco Industries p.l.c.
    $BTI
    12/12/2025Buy
    Kepler
    British American Tobacco Industries p.l.c.
    $BTI
    9/8/2025$62.00Hold → Buy
    Argus
    British American Tobacco Industries p.l.c.
    $BTI
    9/2/2025Sector Perform → Underperform
    RBC Capital Mkts
    British American Tobacco Industries p.l.c.
    $BTI
    7/9/2025Buy
    Jefferies
    More analyst ratings

    $BTI
    $MO
    $UL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Altria to Present at the 2026 Consumer Analyst Group of New York Conference

    Altria Group, Inc. (Altria) (NYSE:MO) will host a webcast of its business presentation at the annual Consumer Analyst Group of New York conference in Orlando, Florida, on Wednesday, February 18, 2026, at approximately 1:00 p.m. Eastern Time. The webcast will feature a presentation by Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Executive Vice President and Chief Financial Officer. The webcast will be in a listen-only mode. Pre-event registration is necessary; directions are posted at www.altria.com/webcasts. An archived copy of the webcast will be available on altria.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260

    2/4/26 10:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Reports 2025 Fourth-Quarter and Full-Year Results; Provides 2026 Earnings Guidance

    Altria Group, Inc. (NYSE:MO) today reports our 2025 fourth-quarter and full-year business results and provides our guidance for 2026 full-year adjusted diluted earnings per share (EPS). "2025 was a year of continued momentum for Altria, marked by strong financial performance, strategic progress across our smoke-free portfolio, new relationships in support of our long-term growth goals and significant cash returns to shareholders," said Billy Gifford, Altria's Chief Executive Officer. "For the full year, we grew adjusted diluted earnings per share by 4.4% and returned $8 billion to shareholders through dividends and share repurchases combined." "We expect to deliver 2026 full-year adjust

    1/29/26 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria to Host Webcast of 2025 Fourth-Quarter and Full-Year Results

    Altria Group, Inc. (Altria) (NYSE:MO) will host a live audio webcast on Thursday, January 29, 2026, at 9:00 a.m. Eastern Time to discuss its 2025 fourth-quarter and full-year business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com. During the webcast, Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Chief Financial Officer, will discuss the Company's 2025 fourth-quarter and full-year business results and answer questions from the investment community and news media. The webcast will be in a listen-only mode. Pre-event registration is neces

    1/15/26 10:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    $MO
    $UL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Unilever PLC downgraded by Deutsche Bank

    Deutsche Bank downgraded Unilever PLC from Buy to Hold

    2/9/26 7:00:29 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    Altria upgraded by UBS with a new price target

    UBS upgraded Altria from Neutral to Buy and set a new price target of $63.00

    1/9/26 8:23:08 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Unilever PLC downgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane downgraded Unilever PLC from Outperform to Neutral and set a new price target of $71.00

    1/8/26 8:42:50 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    $BTI
    $MO
    $UL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Davis Robert Matthews bought $48,599 worth of shares (1,200 units at $40.50), increasing direct ownership by 16% to 8,473 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:08:44 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Clarke Ian L.T. bought $44,625 worth of shares (1,100 units at $40.57), increasing direct ownership by 18% to 7,145 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:03:21 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    $MO
    $UL
    SEC Filings

    View All

    SEC Form 6-K filed by British American Tobacco Industries p.l.c.

    6-K - British American Tobacco p.l.c. (0001303523) (Filer)

    2/13/26 1:29:17 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Unilever PLC

    6-K - UNILEVER PLC (0000217410) (Filer)

    2/13/26 1:24:50 PM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 6-K filed by Unilever PLC

    6-K - UNILEVER PLC (0000217410) (Filer)

    2/13/26 11:16:10 AM ET
    $UL
    Package Goods/Cosmetics
    Consumer Discretionary

    $BTI
    $MO
    $UL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gifford William F. Jr. gifted 15,700 shares, decreasing direct ownership by 2% to 673,427 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    2/6/26 2:55:27 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Director Munoz George

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    1/20/26 5:03:46 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SVP, Chief HR Off. & CCO Whitaker Charles N. was granted 17,168 shares, increasing direct ownership by 10% to 194,464 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    12/11/25 2:35:42 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    $MO
    $UL
    Leadership Updates

    Live Leadership Updates

    View All

    Altria Group, Inc. Announces Retirement of CEO Billy Gifford and Appointment of Sal Mancuso as Successor

    Altria Group, Inc. (Altria) (NYSE:MO) announces today that Billy Gifford, Altria's Chief Executive Officer (CEO), has decided to retire, effective May 14, 2026 at the conclusion of the 2026 Annual Meeting of Shareholders (2026 Annual Meeting). Billy has had a distinguished career of over 30 years with the Altria family of companies and has served as Altria's CEO since 2020. Altria's Board of Directors (Board) has elected Salvatore (Sal) Mancuso to serve as Altria's CEO upon Billy's retirement. To facilitate a smooth transition, Billy plans to serve as a consultant to Altria upon his retirement through at least the end of 2026. Additionally, the Board elected Heather Newman to serve as Altri

    12/11/25 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Charlotte's Web Appoints M. Borgia Walker to Board of Directors

    Accomplished Executive Brings Three Decades of Transformation and Financial Leadership Experience from Global Consumer Goods and Financial Services Industries LOUISVILLE, Colo., Oct. 21, 2025 /PRNewswire/ - (TSX:CWEB) (OTCQB:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, is pleased to announce the appointment of M. Borgia Walker to its Board of Directors, effective November 1, 2025. Ms. Walker brings extensive global leadership experie

    10/21/25 8:15:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group, Inc. Announces Retirement of Director George Muñoz from Board of Directors

    Altria Group, Inc. (Altria) (NYSE:MO) -- George Muñoz, a director of Altria since 2004, notified Altria of his decision to retire from service on our Board of Directors (Board) following the completion of his current term. Consequently, Mr. Muñoz will not stand for re-election to our Board at our 2026 Annual Meeting of Shareholders, which Altria anticipates holding on May 14, 2026. "George has made extensive and significant contributions to Altria over more than 20 years," said Kathryn McQuade, Altria's independent Chair of the Board. "We thank George for his long-standing and valuable service and wish him the very best upon his retirement." Mr. Muñoz is Chair of the Compensation and Ta

    10/9/25 8:35:00 AM ET
    $LAUR
    $MO
    Other Consumer Services
    Real Estate
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    $MO
    $UL
    Financials

    Live finance-specific insights

    View All

    Altria Reports 2025 Fourth-Quarter and Full-Year Results; Provides 2026 Earnings Guidance

    Altria Group, Inc. (NYSE:MO) today reports our 2025 fourth-quarter and full-year business results and provides our guidance for 2026 full-year adjusted diluted earnings per share (EPS). "2025 was a year of continued momentum for Altria, marked by strong financial performance, strategic progress across our smoke-free portfolio, new relationships in support of our long-term growth goals and significant cash returns to shareholders," said Billy Gifford, Altria's Chief Executive Officer. "For the full year, we grew adjusted diluted earnings per share by 4.4% and returned $8 billion to shareholders through dividends and share repurchases combined." "We expect to deliver 2026 full-year adjust

    1/29/26 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Declares Regular Quarterly Dividend of $1.06 Per Share

    Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.06 per share, payable on January 9, 2026 to shareholders of record as of December 26, 2025. The ex-dividend date is December 26, 2025. View source version on businesswire.com: https://www.businesswire.com/news/home/20251210780457/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 www.altria.com/contact-us/media

    12/10/25 1:30:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Reports 2025 Third-Quarter and Nine-Months Results; Announces Expanded Share Repurchase Program; Narrows 2025 Full-Year Earnings Guidance

    Altria Group, Inc. (NYSE:MO) today reports our 2025 third-quarter and nine-months business results, announces the expansion of our existing share repurchase program and narrows our guidance for 2025 full-year adjusted diluted earnings per share (EPS). "Altria continued to build significant momentum in the third quarter with exciting progress across our businesses," said Billy Gifford, Altria's Chief Executive Officer. "Our core tobacco businesses remained resilient; we advanced our smoke-free portfolio; and we opened new pathways for long-term adjacent growth in international modern oral and U.S. non-nicotine innovation." "We also continue to demonstrate our commitment to returning valu

    10/30/25 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    $MO
    $UL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Altria Group Inc. (Amendment)

    SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)

    2/13/24 4:58:48 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

    SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

    2/9/24 6:03:23 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

    SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

    2/9/24 5:46:32 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care